Verve Therapeutics
VERV
#6836
Rank
A$0.72 B
Marketcap
$8.20
Share price
9.83%
Change (1 day)
-23.38%
Change (1 year)

P/S ratio for Verve Therapeutics (VERV)

P/S ratio as of April 2025 (TTM): 14.4

According to Verve Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.9448. At the end of 2024 the company had a P/S ratio of 15.8.

P/S ratio history for Verve Therapeutics from 2021 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202415.8-83.47%
202395.3-84.47%
2022614
2021N/A